| Burkina Faso | Senegal |
| DGPML, CNVPS, CERS | DPM, CNERS |
| Out of 34 trials authorized • One (1) single inspection (2%) • Three (3) field visits (8%) | • No inspection • progress report |
| Monitoring of adverse events • Notification tools and circuit | Monitoring of adverse events • Notification tools and circuit |